Skip to the content
logo mainlogo darklogo light
logo main
logo main
  • Home
  • About US
  • Science
  • Impact
  • News
  • CONTACT
April 15, 2025
NEWS

AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development

Funding from SPRIND and Family Offices accelerates preparation of ATL-105 for clinical development in lead indication non-CF related bronchiectasis by 2026 Munich, Germany – 15.0

Read More
by philipp
September 18, 2024
NEWS

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board

Leading Expert in Respiratory Medicine Supporting AATec in Product Development in Non-CF Bronchiectasis Munich, Germany – 18.09.2024 – AATec Medical GmbH (AATec), a biotech com

Read More
by philipp
July 17, 2023
NEWS

AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin

GO BACK TO NEWS

Read More
by mcservices

2024 | Copyright ©AATec Medical GmbH

  • Imprint
  • Privacy Policy

  • HomeHome
  • About USAbout US
  • ScienceScience
  • ImpactImpact
  • NewsNews
  • CONTACTCONTACT

Follow us on